𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro and in vivo antitumour activity of a chimeric anti-CD19 antibody

✍ Scribed by Geoffrey A. Pietersz; Li Wenjun; Vivien R. Sutton; Jane Burgess; Ian F. C. McKenzie; Heddy Zola; Joseph A. Trapani


Book ID
105309606
Publisher
Springer-Verlag
Year
1995
Tongue
English
Weight
831 KB
Volume
41
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Chimeric, divalent and tetravalent anti-
✍ Xiao-Yun Liu; Laurentiu M. Pop; Lydia Tsai; Iliodora V. Pop; Ellen S. Vitetta πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 295 KB

## Abstract CD19 is an attractive therapeutic target for treating human B‐cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37‐DcVV) anti‐CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19‐positive (CD19^+^) tumor cel